Introduction {#s1}
============

Brain development depends on the combined effects of incompletely understood genetic and environmental factors. The majority of dry weight in an adult brain is composed of lipids, 35% of which are long chain polyunsaturated fatty acids (LC-PUFAs) [@pone.0017181-Haag1]. During development the brain is more highly enriched than most other tissues in LC-PUFAs that are essential for efficient neurogenesis, myelination, neurite outgrowth, dendritic arborisation and neurotransmission [@pone.0017181-Uauy1]--[@pone.0017181-Marza1]. During pregnancy, the fetus is supplied with preformed maternal LC-PUFAs by placental transfer. After birth breast milk provides a unique supply of crucial LC-PUFAs including eicosapentaenoic acid (EPA), arachidonic acid (AA) and docosahexanoic acid (DHA), which support the accretion of LC-PUFA in the brain growth spurt that takes place during the third trimester of pregnancy and the first two years of life [@pone.0017181-Schuchardt1], [@pone.0017181-Sauerwald1]. Higher concentrations of DHA and AA, rapidly incorporated in the developing brain, are found in infants who are breastfed in comparison with infants fed with unsupplemented formulas [@pone.0017181-Makrides1]. However, it remains controversial whether breastfeeding provides a direct nutritional advantage for child cognition-- attributed in part to the high levels and range of LC-PUFAs-- or simply reflects more favorable socio-environmental factors-- no fully controlled in statistical analysis-- among women who breast feed [@pone.0017181-Anderson1]--[@pone.0017181-Simmer1].

LC-PUFA synthesis is controlled by key enzymes (desaturases and elongases) encoded by the *FADS* gene cluster and the *ELOVL* gene family (**see Supporting Information [Figure S1](#pone.0017181.s002){ref-type="supplementary-material"}**). Fatty acid desaturases are encoded by *FADS1* and *FADS2* genes, which build a gene cluster together with a third desaturase gene, *FADS3* [@pone.0017181-Marquardt1]. *FADS2* is the rate-limiting step on the metabolic pathway leading to AA and DHA production [@pone.0017181-Sprecher1]. Genes involved in the elongation of LC-PUFAs include *ELOVL4* (specifically expressed in human retina), and *ELOVL2* and *ELOVL5* that are expressed in brain [@pone.0017181-Jakobsson1]. Polymorphisms of the *FADS* gene cluster and *ELOVL2* gene have been reported to be associated with plasma variation in LC-PUFA levels [@pone.0017181-Tanaka1]--[@pone.0017181-MoltPuigmart1]. In addition, in the absence of dietary supplies, desaturation and elongation processes may play a role in ensuring supply of LC-PUFAs such as DHA and AA [@pone.0017181-Heird1].

Research on the effects of LC-PUFA supply during pregnancy and lactation taking into account maternal and child inter-individual genetic variation in fatty acid desaturase and elongase activities may be critical to elucidate whether breastfeeding influences cognitive development as a unique source of LC-PUFAs, independent of other risk factors [@pone.0017181-Smith1]. Unlike breastfeeding practises, genotype is not likely to be influenced by social, behavioural or lifestyle variables. Therefore, using the principles of Mendelian randomization, associations between the functional polymorphism of *FADS* and *ELOVL* genes and child cognition are unlikely to be confounded by social or behavioral factors and are more likely to be representative of a causal relationship. The aims of this study were: 1) to determine whether maternal genetic variants in the *FADS* cluster and *ELOVL* genes contribute to differences in LC-PUFA levels in first breast milk (colostrum); 2) to analyze whether these maternal variants are related to cognitive outcomes in the child; and 3) to assess whether children\'s variants in these genes modify breastfeeding effects on cognition. To achieve these objectives we used data from two Spanish population-based birth cohorts included in the INMA (INfancia y Medio Ambiente \[Environment and Childhood\]) Project.

Methods {#s2}
=======

Ethics statement {#s2a}
----------------

Written informed consent was obtained from all participants and the study was approved by the Clinical Research Ethical Committee of the Municipal Institute of Health Care (CEIC-IMAS), Barcelona.

Study design and participants are summarized in [Figure 1](#pone-0017181-g001){ref-type="fig"}. Distribution of child and maternal characteristics of participants and non participants are showed in the Online Repository (**see Supporting Information [Table S5](#pone.0017181.s007){ref-type="supplementary-material"}**).

![Flow diagram for study design and participant selection.](pone.0017181.g001){#pone-0017181-g001}

The INMA-Sabadell birth cohort {#s2b}
------------------------------

The INMA-Sabadell cohort was established in Sabadell (Barcelona, Spain) between 2004 and 2006 [@pone.0017181-RibasFit1]. A total of 657 women were enrolled at the first trimester of pregnancy (participation rate was 60%, 657 of 1097 eligible women), and 622 (94%) followed until the child\'s birth. Detailed information about child feeding was completed by interviewer-administered questionnaires with mothers at 6 and 14 months. Exclusively breastfeeding was defined as receiving breast milk only but allowing supplementation of non-milk liquids according to the WHO\'s definition [@pone.0017181-World1]. Mental development was assessed at age 14 months (range 12--17 months) by 2 specially trained psychologists using the Bayley Scales of Infant Development, first edition [@pone.0017181-Bayley1], [@pone.0017181-Vrijheid1]. The Bayley Scale for Cognitive Development is composed by two scales, the mental development and psychomotor. For the present study, the main outcome was the score in the mental development scale consisting in 163 items that assess age-appropriate cognitive development in areas such as performance ability, memory, and first verbal learning.

The AMICS INMA-Menorca birth cohort {#s2c}
-----------------------------------

The Menorca Asthma Multicenter Infant cohort Study (AMICS) is a population-based birth cohort established in the island of Menorca (Spain) in 1997--98. A total of 482 children were recruited at birth from 492 pregnant women residing on the island [@pone.0017181-Polk1]. Breastfeeding was assessed by interviewer-administered questionnaires to mothers three times at ages 6 months, 14 months, and 2 years[@pone.0017181-RibasFit2]. Infants not breastfeed received formula feeding at a time before LC-PUFA supplementation of formula became widely available in Spain. Two certified psychologists performed the neuropsychological testing of the children at age 4 years measuring cognitive functioning with the Spanish version of the McCarthy Scales of Children\'s Abilities (MCSA), consisting of 5 sub-scales assessing several cognitive domains (verbal, perceptual-performance, quantitative, memory, and motor) and a general cognitive index [@pone.0017181-McCarthy1]--[@pone.0017181-Morales1]. For the present study score in the general cognitive index was used as the main outcome.

Genotyping procedure {#s2d}
--------------------

All genotyping processes were performed at the Barcelona Node of the Spanish National Genotyping Centre (CEGEN). In the INMA-Sabadell cohort maternal DNA samples were extracted from blood obtained at first trimester of pregnancy. Child DNA samples were extracted from cord blood obtained at birth in the INMA-Sabadell cohort (100%) and from blood (85%) obtained at age 4 in the INMA-Menorca cohort (15 % from saliva). Details of the SNP selection process are provided in the supplementary information material (**see Supporting information [Appendix S1](#pone.0017181.s001){ref-type="supplementary-material"}**). Rs numbers, gene location, minor allele frequencies and Hardy-Weinberg Equilibrium values are shown in the Online Repository (**see Supporting Information [Table S1](#pone.0017181.s003){ref-type="supplementary-material"}**). Genotyping was performed blind to measures of breastfeeding and LC-PUFA exposure, as well as, cognition scores. Finally, twenty-six SNPs out of 36 initially selected were successful genotyped and included in the analysis (13 in the *FADS* gene cluster, 6 in *ELOVL2* gene, and 7 in *ELOVL5* gene). Linkage disequilibrium (LD) parameters (D\' and r2) were estimated using the Haploview software (**see Supporting Information [Table S6](#pone.0017181.s008){ref-type="supplementary-material"}, [Table S7](#pone.0017181.s009){ref-type="supplementary-material"}, [Table S8](#pone.0017181.s010){ref-type="supplementary-material"}**).

Measurement of colostrum LC-PUFA {#s2e}
--------------------------------

Colostrum samples were obtained from the first 270 willing participants from the INMA-Sabadell cohort. Samples were collected during the first 48--96 hours post-partum, transported to the laboratory in ice boxes less than 2 hours after collection and stored at −80°C until analyzed. The following fatty acids were identified and quantified according to the method developed by Molto-Puigmarti et al. [@pone.0017181-MoltPuigmart2]: linoleic acid (LA), α-linolenic acid (ALA); AA; eicosatrienoic acid (DGLA); EPA; docosapentaenoic acid (DPA) and DHA. The ratio between the concentrations of the product-substrate pairs of the desaturase and elongase reactions have been previously used as strong indicators for the efficiency of the enzymes and as a proxy for enzymatic activity [@pone.0017181-Gieger1]. Thus, we further calculated the following ratios as surrogate indexes of FADS and ELOVL5 enzymatic activities: AA:DGLA for FADS1, DGLA:LA and DHA:DPA for FADS2 as previously described [@pone.0017181-Warensj1], [@pone.0017181-Bokor1], and DPA:EPA for ELOVL5 activity. In addition, ratios EPA/AA and DHA/AA, which reflect the proportions of key n-3 to n-6 fatty acids essential for brain growth and function, were calculated.

Statistical analysis {#s2f}
--------------------

The outcomes of interest, general cognitive index from McCarthy test and the mental development scale score from the Bayley test, were standardized to a mean of 100 corresponding to the mean of the raw scores, and standard deviation of 15. LC-PUFAs were log-transformed to achieve a normal distribution. Bivariate analyses exploring how breastfeeding behaviors and colustrum LC-PUFA profiles were related to either child cognition or to genetic variants used χ^2^-tests for categorical data and Krukall-Wallis tests for continuous data. For genetic variables, departure from HWE within mothers and children was evaluated using a χ^2^-test.

Associations between maternal genetic variants and both child cognition and LC-PUFA levels and ratios in colostrum were assessed using multivariable linear models and evaluated using likelihood ratio tests. The resultant regression coefficients represent the mean difference in cognitive scores or LC-PUFA levels between genotype groups. All variables significantly associated with general cognitive scores in the bivariate models (p\<0.2) were included in the multivariate model, and only retained if they had an at least marginally significant association (p\<0.1) or modified the coefficient by at least 5% [@pone.0017181-Julvez1], [@pone.0017181-Morales1], [@pone.0017181-RibasFit3]. Final multivariate models were adjusted for sex, child age (days), psychologist, quality of neuropsychological test, maternal education, breastfeeding, and use of gas stove at home. For associations between LC-PUFA and maternal genotype, unadjusted results are reported since incorporating potential confounders in multivariable linear models including maternal age, body mass index, smoking habits, and maternal diet intake of fish, seafood, meat and egg intakes measured by a 101-item validated food frequency questionnaire during pregnancy did not meet criteria for confounding (change-in-estimate ≥5%), and finally were excluded for parsimony. Bonferroni correction was applied to take multiple testing into account and p value thresholds were set at 0.002 (0.05/23).

We tested interactions between child\'s genetic variants and breastfeeding, as well as, between LC-PUFA levels and n-3/n-6 ratios in colostrum. Linear models were also used to assess whether children\'s genetic variants modified the effects of breastfeeding behaviors on cognitive test scores, adjusting for other covariables. Similarly, linear models were used to assess whether children\'s genetic variants modified the effects of colostrum LC-PUFA profiles on cognitive scores. For these analyses, selected single LC-PUFA and n-3/n-6 ratios were dichotomized as close as possible to p = 0.50, and analyses were restricted to breastfed children. The resultant regression coefficient gives the mean difference in cognitive scores between the two groups (e.g. children exposed to low vs. high colostrum fatty acid concentrations or children with contrasting genetic variants), having controlled for confounders. Statistical analysis was performed with R statistical package version 2.9.1 using the SNPassoc package [@pone.0017181-Gonzlez1].

Results {#s3}
=======

Associations between maternal *FADS* gene cluster and *ELOVL* gene family SNPs and LC-PUFA profiles in colostrum {#s3a}
----------------------------------------------------------------------------------------------------------------

Associations between maternal genetic variants and LC-PUFA levels in colostrum are showed in the Online Repository (**see Supporting Information [Table S2](#pone.0017181.s004){ref-type="supplementary-material"}**). The rs174537-T, rs174570-T, rs2072114-G, rs174602-G, rs526126-G, rs174626-C, rs174464-T, and rs174468-G alleles in the *FADS* cluster were related to lower levels of AA ([Table S2](#pone.0017181.s004){ref-type="supplementary-material"}). The rs174602-G, and 174464-T in the *FADS* cluster were associated with lower levels of DHA, and other SNPs in the cluster showed a trend to be associated with DHA levels in the same direction as the observed for AA ([Table S2](#pone.0017181.s004){ref-type="supplementary-material"}). Regarding elongases rs953413-A and rs3798719-T in *ELOVL2* gene were associated with higher EPA levels. None of the SNPs in the *ELOVL5* were associated with AA, EPA or DHA levels at a p value of 0.05, although a trend was observed for rs12207094 and EPA levels. Finally, several SNPs in the *FADS* cluster (rs174464 and rs174468), *ELVOL2* (rs3734397, rs953413 and rs3798719) and *ELVOL5* (rs17544159, rs9395855 and rs12207094) genes were associated with EPA/AA ratio and/or DHA/AA ratio ([Table S2](#pone.0017181.s004){ref-type="supplementary-material"}).

[Table 1](#pone-0017181-t001){ref-type="table"} shows the associations observed between the *FADS* cluster and *ELOVL* gene family SNPs and enzymatic indexes estimated based on LC-PUFA profiles. The rs174537-T, rs968567-A, rs2072114-G, rs526126-G, rs174626-C, rs174627-T, rs174464-T, rs174468-G alleles were associated with lower FADS1 index. Three of the previous SNPs (rs174537, rs968567 and rs174627) were inversely associated with FADS2 index. Moreover, the rs174602-G allele was associated with lower FADS2 index (capacity to synthesize DHA from EPA). In *ELOVL5*, the rs2397142-C allele was nominally associated with lower capacity to metabolize EPA to DPA.

10.1371/journal.pone.0017181.t001

###### FADS1, FADS2 and ELOVL5 enzymatic indexes according to maternal genotypes and LC-PUFA levels in colostrum.

![](pone.0017181.t001){#pone-0017181-t001-1}

                                         11         12        22                                      
  ------------------- ----------- ----- ----- -------------- ----- -------------- ---- -------------- -------------
  **FADS1 index**                                                                                     
  **AA:DGLA**                                                                                         
  Gene                    SNP                                                                         
  * FADS*              rs174537    G/T   142   1.46 (0.02)    109   1.22 (0.03)    19   0.96 (0.08)    1.0×10^−20^
  * FADS*              rs968567    G/A   200   1.44 (0.02)    57    1.04 (0.03)    3    0.76 (0.08)    2.4×10^−29^
  * FADS*              rs2072114   A/G   219   1.35 (0.02)    49    1.23 (0.04)    2    0.93 (0.04)      0.0026
  * FADS*              rs526126    C/G   160   1.37 (0.02)    66    1.25 (0.04)    2    1.06 (0.19)      0.0031
  * FADS*              rs174626    T/C   66    1.43 (0.03)    141   1.32 (0.02)    63   1.25 (0.04)      0.0007
  * FADS*              rs174627    C/T   209   1.37 (0.02)    56    1.20 (0.04)    5    0.99 (0.14)    7.5×10^−06^
  * FADS*              rs174464    C/T   116   1.41 (0.03)    103   1.26 (0.03)    19   1.20 (0.07)    7.2×10^−05^
  * FADS*              rs174468    G/A   100   1.28 (0.03)    124   1.34 (0.03)    40   1.43 (0.04)      0.0078
  **FADS2 indexes**                                                                                   
  **DGLA:LA**                                                                                         
  Gene                    SNP                                                                         
  * FADS*              rs174537    G/T   142   0.06 (0.001)   109   0.07 (0.002)   19   0.09 (0.008)   8.5×10^−06^
  * FADS*              rs968567    G/A   200   0.06 (0.001)   57    0.09 (0.003)   3    0.11 (0.016)   1.1×10^−15^
  * FADS*              rs174627    C/T   209   0.06 (0.001)   56    0.07 (0.003)   5    0.08 (0.020)     0.0129
  **DHA:EPA**                                                                                         
  Gene                    SNP                                                                         
  * FADS*              rs174602    A/G   209   1.65 (0.03)    56    1.56 (0.03)    5    1.42 (0.05)      0.0039
  **ELOVL5 index**                                                                                    
  **DPA:EPA**                                                                                         
  Gene                    SNP                                                                         
  * ELOVL5*            rs2397142   C/G   125   7.81 (0.31)    112   8.08 (0.42)    31   10.02 (1.28)     0.0362

INMA Sabadell cohort.

Only statistically significant associations are showed.

Major allele:1; minor allele:2. Data are means (standard error). \*P-values for additive genetic models assuming a trend per copy of the minor allele.

AA: Arachidonic acid; DGLA: Eicosatrienoic acid; LA: Linoleic acid; DHA: Docosahexaenoic acid; DPA: Docosapentaenoic acid; EPA: Eicosapentanoic acid.

Associations between maternal polymorphisms in the *FADS* gene cluster and *ELOVL* genes and child cognition {#s3b}
------------------------------------------------------------------------------------------------------------

In the *FADS* gene cluster, we found that maternal SNPs rs968567, rs174602, rs174627 and rs174464 were nominally associated with child cognition ([Table 2](#pone-0017181-t002){ref-type="table"}). In general the allele associated with higher child cognition scores were the alleles associated with high FADS2 index (the limiting enzyme of the pathway), which correspond to low FADS1 index (as both enzymatic ratios are estimated using DGLA levels). The most significant association found was for the maternal SNP rs174627 (p\<0.001). In particular children of mothers carrying at least one copy of the minor allele (T) for this variant had higher cognition scores compared to children of mothers homozygotes for the major allele ([Table 2](#pone-0017181-t002){ref-type="table"}). None of the SNPs in the *ELOVL2* gene showed a significant association with child cognition. Regarding the *ELOVL5* gene, we found that children of mothers carrying the rs17544159-C allele (associated with higher EPA/AA ratio in colostrums) or carrying the rs12207094-T allele (associated with both higher EPA/AA and DHA/AA ratios in colostrum) had higher cognition scores related to children of mothers homozygote for the major allele.

10.1371/journal.pone.0017181.t002

###### Association between maternal genetic variants and child cognition at age 14 months.

![](pone.0017181.t002){#pone-0017181-t002-2}

                                        11        12        22                                     
  ------------------------ ----- ----- ----- ------------- ----- ------------- ---- -------------- ---------
  ***FADS*** **cluster**                                                                           
  rs174537                  400   G/T   203   99.5 (1.1)    169   101.0 (1.2)   28   100.7 (2.5)     0.130
  rs968567                  385   G/A   296   99.4 (0.9)    83    102.6 (1.6)   6    106.3 (4.7)     0.023
  rs174570                  347   C/T   279   101.0 (0.9)   64    98.5 (2.0)    4     95.8 (3.8)     0.330
  rs2072114                 399   A/G   310   100.2 (0.9)   87    100.5 (1.5)   2    100.1 (5.7)     0.880
  rs174602                  393   A/G   230   101.3 (0.9)   137   98.8 (1.4)    26    98.3 (2.9)     0.027
  rs526126                  336   C/G   234   99.9 (1.0)    99    102.8 (1.6)   3    105.8 (8.3)     0.059
  rs174626                  399   T/C   102   99.9 (1.4)    209   99.5 (1.1)    88   102.2 (1.7)     0.240
  rs174627                  399   C/T   313   99.4 (0.9)    82    103.1 (1.5)   4    109.4 (10.3)   \<0.001
  rs7482316                 382   A/G   310   100.7 (0.9)   70    98.0 (2.0)    2    97.2 (20.1)     0.474
  rs174464                  348   C/T   174   98.3 (1.2)    149   102.2 (1.2)   25   106.6 (2.2)     0.008
  rs174468                  392   G/A   141   100.4 (1.4)   187   100.1 (1.1)   64    99.9 (1.8)     0.563
  ***ELOVL2***                                                                                     
  rs3734397                 400   A/G   212   100.9 (0.9)   168   99.1 (1.2)    20   102.7 (4.5)     0.291
  rs953413                  387   G/A   114   99.2 (1.4)    193   101.1 (1.1)   80   100.0 (1.7)     0.398
  rs10498676                392   G/A   288   100.0 (0.9)   94    101.7 (1.6)   10    92.6 (7.6)     0.583
  rs6936315                 338   T/C   241   100.5 (1.0)   89    101.0 (1.7)   8    102.2 (4.1)     0.844
  rs3798719                 385   C/T   196   99.7 (1.2)    151   101.6 (1.2)   38    96.3 (2.2)     0.849
  rs13204015                389   T/C   356   100.7 (0.8)   32    98.1 (3.1)    1     97.2 (0.0)     0.309
  ***ELOVL5***                                                                                     
  rs17544159                383   A/C   332   99.4 (0.8)    51    105.1 (2.0)   \-        \-         0.016
  rs2281274                 394   T/C   210   99.7 (1.1)    147   100.6 (1.3)   37   101.7 (2.4)     0.275
  rs2294859                 392   T/C   332   100.8 (0.9)   56    99.2 (1.7)    4     92.9 (8.3)     0.983
  rs9395855                 399   T/G   105   98.3 (1.6)    204   101.0 (1.0)   90   100.8 (1.7)     0.633
  rs11968589                390   C/T   310   100.5 (0.9)   74    99.1 (1.9)    6     96.2 (5.6)     0.601
  rs2397142                 397   C/G   173   99.7 (1.1)    178   100.1 (1.2)   46   101.9 (2.1)     0.499
  rs12207094                398   A/T   287   99.1 (0.9)    106   102.8 (1.4)   5    119.1 (7.4)     0.003

INMA Sabadell cohort.

Major allele:1; minor allele:2. Data are means (standard error, SE).

\*P value for the additive genetic models assuming a trend per copy of the minor allele.

All models are adjusted for sex, child age (days), psychologist, quality of neuropsychological test, maternal education, breastfeeding, and use of gas stove at home.

Associations between child polymorphisms in the *FADS* gene cluster and *ELOVL* genes and child cognition {#s3c}
---------------------------------------------------------------------------------------------------------

Regarding child genetic variants, after Bonferroni correction no statistically significant associations were found between child polymorphisms and cognition, and we could no replicate the nominal associations found in Menorca cohort (**see Supporting Information [Table S3](#pone.0017181.s005){ref-type="supplementary-material"}**).

Child polymorphisms in the *FADS* cluster and *ELOVL5* gene modify breastfeeding effect on cognition {#s3d}
----------------------------------------------------------------------------------------------------

We found two statistically significant gene-breastfeeding interactions that were replicated in both cohorts. We found that not being breastfed conferred a disadvantage in cognition (9 point in the INMA-Menorca cohort and 8 points in the INMA-Sabadell cohort) among children GG homozygotes for rs174468 (low FADS1 index), but not among those carrying at least one copy of the A allele (high FADS1 index) ([Figure 2](#pone-0017181-g002){ref-type="fig"}). In addition, not being breastfed resulted in a disadvantage in cognition (8-point in INMA-Menorca and 5-point in the INMA-Sabadell) among children CC homozygotes for rs2397142 (low ELOVL5 index), but not among those carrying at least one copy of the G allele (high ELOVL5 index). In contrast, breastfed children did not differ in cognition score irrespective of their genetic variants in these polymorphisms.

![Child cognition scores by child\' genetic SNPs in the *FADS* gene cluster (rs174468) and *ELOVL5* gene (rs2397142), by breastfeeding and cohort.\
Bars represent standard error. ^1^Adjusted for sex, school trimester at testing, maternal social class, maternal education, maternal smoking and alcohol consumption in pregnancy, indoor nitrogen dioxide (NO2) levels. ^2^Adjusted for sex, child age (in days), psychologist, quality of neuropsychological test, maternal education, and use of gas stove at home.](pone.0017181.g002){#pone-0017181-g002}

Children\' genotypes were not related to potential confounders including maternal social class, maternal education level, reproductive outcomes, diet intakes, or maternal tobacco and alcohol consumption during pregnancy. In addition, the prevalence of breastfeeding was similar across children with different genotypes (**see Supporting Information [Table S4](#pone.0017181.s006){ref-type="supplementary-material"}**).

Child polymorphism in *ELOVL5* gene modifies the effect of colostrum LC-PUFA levels on cognition {#s3e}
------------------------------------------------------------------------------------------------

In the INMA-Sabadell cohort we analyzed whether child genetic variants interacted with LC-PUFA levels in colostrum to influence cognition. Among breastfed children carrying at least one G allele for rs2397142 (high ELOVL5 index), there was no association between cognition and LC-PUFA levels in colostrum. In contrast, among children CC homozygotes for rs2397142 (low ELOVL5 index), exposure to high levels of EPA, and high EPA/AA and DHA/AA ratios were associated with a 6.7-, 8.6- and 10.1-points advantage in scores, respectively, relative to children exposed to low levels ([Table 3](#pone-0017181-t003){ref-type="table"}).

10.1371/journal.pone.0017181.t003

###### Child cognition scores[\*](#nt110){ref-type="table-fn"} (mean and standard error (SE)) by levels of LC-PUFA in colostrum and by rs2397142 (*ELOVL5* gene) among breast fed children of the INMA Sabadell cohort.

![](pone.0017181.t003){#pone-0017181-t003-3}

                      rs2397142 CC   rs2397142 CG-GG                           
  ------------------ -------------- ----------------- ----- ---- ------- ----- -------
  **EPA/AA ratio**                                                             
  Low                      25             96.1         3.5   41   100.7   2.3   0.029
  High                     40             104.8        2.4   37   98.0    2.9  
  **DHA/AA ratio**                                                             
  Low                      35             96.8         2.8   39   98.6    2.7   0.018
  High                     30             106.9        2.7   39   100.2   2.4  

AA: Arachidonic acid; EPA: Eicosapentanoic acid; DHA: Docosahexaenoic acid.

Adjusted for sex, age (days), psychologist, quality of neuropsychological test, maternal education, and use of gas stove at home.

Discussion {#s4}
==========

In the present study, we analysed polymorphisms in genes encoding the key enzymes involved in LC-PUFA synthesis in mothers and their offspring to disentangle their role in modifying potential nutritional advantages of breastfeeding on child cognition. Maternal genetic variants in the *FADS* gene cluster and *ELOVL5* gene were associated with higher colostrum levels of n-3 LC-PUFA (i.e. EPA and DHA) as well as with higher cognitive scores in their children. In infants, we found that genetic variants in the *FADS* cluster and *ELOVL5* gene modified the effects of breastfeeding on cognition. Children with variants associated with lower synthesis of LC-PUFA had higher scores when breastfed, while those with greater capacity to synthesize these fatty acids had higher scores regardless of breastfeeding practises. We confirmed these gene-breastfeeding interactions in two independent population-based birth cohorts. Moreover, we ruled out the possibility that these findings were due to potential confounders including correlations between genes and exposures, intrauterine growth differences, dietary or sociodemographic factors.

Maternal genetic variation in LC-PUFA metabolizing enzymes, colostrum LC-PUFA profile and child cognition {#s4a}
---------------------------------------------------------------------------------------------------------

Although fatty acid desaturase activities are present in the mammary gland [@pone.0017181-RodriguezCruz1], few studies have assessed whether maternal polymorphisms in key enzymes involved in LC-PUFA synthesis influence the composition of breast milk [@pone.0017181-Xie1], [@pone.0017181-MoltPuigmart1], and the effects on child phenotypes such as cognition have not been investigated so far. To this purpose we used LC-PUFA measurements from early breast milk (colostrum), since its LC-PUFA composition is related to the LC-PUFA composition of brain tissue in the newborn [@pone.0017181-Xiang1]. Our results on the direction of the association between maternal genetic variants in desaturases and LC-PUFA levels in colostrum are consistent with previous findings showing associations between several SNPs in the *FADS* cluster and plasma, erythrocyte and breast milk LC-PUFA levels in adults [@pone.0017181-Tanaka1]--[@pone.0017181-Xie1], [@pone.0017181-MoltPuigmart1], [@pone.0017181-RodriguezCruz1]. In our study, the two maternal *FADS* cluster SNPs most strongly related to disparities in colostrum LC-PUFA levels were rs174537 previously reported to be associated with LC-PUFA levels in genome-wide association studies [@pone.0017181-Tanaka1], and rs968567 recently reported to influence *FADS2* transcription in an *in vitro* system [@pone.0017181-Lattka1]. We also identified other *FADS* cluster SNPs significantly related to variation in colostrum LC-PUFA levels as well as with FADS enzymatic indexes previously described [@pone.0017181-Xie1], [@pone.0017181-Bokor1]. In general, minor alleles in the *FADS* cluster (associated with low FADS1 index and high FADS2 indexes) were related to higher child cognitive scores, although no statistically significant associations were found for all of them. FADS2 is considered the limiting enzyme which strengthens the importance of the present results. Since not all the LC-PUFAs were measured, we could not evaluate the same ratios in the n-3 pathway. However, the fact that both types of LC-PUFA compete for the same enzymes system, suggests that similar results are expected in the n-3 pathway. In addition, although tissue LC-PUFA levels are also determined by dietary intake, associations between the analyzed SNPs and both LC-PUFA colostrum levels and desaturase and elongase enzymatic activity estimates did not change after taking into account information on maternal diet habits including fish, seafood, meat and eggs intakes measured by food frequency questionnaire during pregnancy.

AA and DHA have been proposed to play important roles in synaptic transmission and plasticity during early brain development [@pone.0017181-Schuchardt1]. Furthermore, the imbalance between n-6 and n-3 fatty acids has been suggested to be related to neuropsychiatric disorders in children [@pone.0017181-Schuchardt1]. Although, infants are capable of synthesizing DHA and AA accumulation of LC-PUFA fatty acids *in utero* are derived predominantly through placental transfer [@pone.0017181-Koletzko1]. Based on the present results, maternal genetic variants influencing fatty acid desaturation and elongation activities-- and thus levels of LC-PUFA in colostrum-- appear to have functional importance for infant brain development. In this regard, we found that children of mothers with genetically determined lower levels of AA, higher EPA/AA, and higher capacity to synthesize DHA and therefore higher DHA/AA ratios, showed a significant advantage in cognition at age 14 months.

Child polymorphisms in LC-PUFA metabolizing enzymes, breastfeeding and child cognition {#s4b}
--------------------------------------------------------------------------------------

After birth, formula fed infants depend on the utilization of body stores or on the endogenous ability to synthesize LC-PUFAs: the latter may help that may compensate for deficient supplies of LC-PUFAs associated with not being breastfed. We found that genetic variants in the *FADS* gene cluster and *ELOVL5* gene in children modified the effect of breastfeeding on cognition; and results were replicated in both cohorts. Not being breastfed conferred a disadvantage in cognition among children with lower FADS1 index, and similarly, not being breastfed conferred a disadvantage among children with lower ELOVL5 index. These results of the *FADS* cluster variant are in general accordance with those reported by Caspi et al. [@pone.0017181-Caspi1]. As proposed by these authors the genetic modification of breastfeeding effects on cognition is unlikely to be directly caused by the analyzed SNPs, but rather mediated by more efficient LC-PUFA processing.

Biological effects of LC-PUFAs on brain function are assumed to be mediated by the availability of LC-PUFA with \>20 carbon atoms and \>3 double bonds (i.e. AA, EPA and DHA) [@pone.0017181-Schuchardt1]. In mammals, *ELOVL5* catalyzes the two carbon elongation process required for the synthesis of DHA from EPA [@pone.0017181-Leonard1]. The modification of breastfeeding effects on child cognition by a SNP in *ELOVL5* found in the present study could be explained by higher capacity in infants with this variant to synthesize 20 carbon fatty acids from their precursors provided by breast milk. While previous studies have focused primarily on the *FADS* gene cluster, interestingly we found that breastfed children who were CC homozygotes (low ELOVL5 index) exposed to higher EPA, EPA/AA and DHA/AA in colostrum had a significant advantage in cognition in comparison to those exposed to lower concentrations. These results suggest that homozygosity for the C allele could be related to less efficient synthesis of DHA from EPA, probably due to decreased transcription or to a less enzyme activity. On the contrary, the presence of at least one G allele could be related to more efficient fatty acid metabolism, which could compensate for deficient supplies of LC-PUFAs derived from not being breastfed or being exposed to breast milk containing lower levels of EPA and DHA. Consistent with this mechanism, experimental studies in baboon neonates have revealed that exposure to different levels of DHA in formulas induced global changes in gene expression in cerebral cortex [@pone.0017181-Kothapalli1], and only a single elongation enzyme was differentially expressed: the analogue to human ELOVL5.

Implications for genetic neuroscience and newborn nutrition {#s4c}
-----------------------------------------------------------

Identifying genes for variation in the range of normal cognitive functioning could help in understanding biological mechanisms and pathways of milder but more-prevalent forms of impaired neurofunctioning, which are often associated with autism, schizophrenia, and attention deficit hyperactivity disorder (ADHD). Complex traits, such as cognition, are the result of combined effects of genetic and environmental factors[@pone.0017181-Posthuma1]; however, gene-environment interactions are repeatedly overlooked in genome-wide scans which could result in unexplained heritability [@pone.0017181-Thomas1]. In addition, the results indicate that breastfeeding offers a real nutritional advantage for child cognition, and that this advantage is related to LC-PUFA profiles. The ratios between n-3 and n-6 fatty acids, particularly EPA/AA and DHA/AA, have been emphasized in infant nutrition [@pone.0017181-Schuchardt1]. Significant improvement in ADHD symptoms have been observed with a significant increase in EPA and DHA supplies, as well as a drop in the AA/EPA ratio [@pone.0017181-Sorgi1]. Also a significant association between a SNP in the *FADS2* gene and ADHD has been reported (carriers of the genetic variant associated with ADHD have greatly elevated AA contents in their serum phosplipids) [@pone.0017181-Brookes1]. These earlier studies and findings from the present study suggest not only a need to increase n-3 (EPA and DHA) in the diet, including in infant formulae, but also perhaps to decrease the n-6 content (i.e. AA). Furthermore, failure to consider genetic heterogeneity in LC-PUFA metabolism in participants may dilute supplementation effects and as a result inconsistent conclusions are derived from randomized controlled trials.

Strengths and limitations {#s4d}
-------------------------

Strengths of this study include the use of data from two independent population-based birth cohorts. We also had both maternal and child genetic information. Cognitive assessment was measured with validated instruments. The observed associations are unlikely to be due to population stratification since the discovery and replication samples were restricted to Caucasian individuals of European origin recruited in Catalonia and in Menorca. Furthermore, the frequency distribution of minor and major alleles was similar in both cohorts and to that listed in the HapMap CEU sample. In comparison with the study by Caspi et al., we assessed the association of both maternal and child genetic variation in fatty acid desaturases and elongases on cognition. Moreover we assessed the genetic variability in the whole *FADS* cluster gene and also in elongase genes involved in the LC-PUFA synthesis pathway. In addition, the use of biomarkers such as colostrum levels of LC-PUFA strengthens the findings.

Among the study limitations we acknowledge the small sample size that has probably limited power to detect associations with small effect sizes and associations with rare variants. Since we measured cognitive function at two different ages, phenotypic heterogeneity between cohorts may have limited our ability to detect some direct associations. However, our main aim was to seek for gene-environment interactions, which probably have a more relevant role in complex traits as cognition. In fact we were able to detect and replicate two gene-breastfeeding interactions with a plausible biological justification. Additionally, a proportion of mothers and children in both cohorts were not included in the present study because of non-participation in the neurodevelopment exam or failure in the genotyping. However, the analysis comparing participants and non-participants did not show any difference in general cognition or sociodemographic characteristics (**see Supporting Information [Table S5](#pone.0017181.s007){ref-type="supplementary-material"}**). We could no collect maternal DNA in Menorca cohort, thus associations between maternal genetic variants and child cognition could not be replicated and future studies are warranted.

Conclusions {#s4e}
-----------

Results of the present study showed that LC-PUFA supplies during pregnancy and lactation, genetically determined by maternal desaturase and elongase activities, appear to have functional importance to the infant brain development. In addition, breastfeeding effects on cognition are also modified by child genetic variants in desaturase and elongase enzymes involved in the control of LC-PUFA pathways. Future research assessing the effects of breastfeeding and LC-PUFA diet supplementation on brain development should take into account genetic heterogeneity in key enzymes of LC-PUFA synthesis.
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